Matthew McStea

Matthew McStea is currently a Bioprocessing Scientist at MeiraGTx, a position held since January 2023, where responsibilities include supporting GMP-compliant activities for the production of sterile gene therapy products and applying relevant practices such as SOPs, GMP, GDP, and data integrity to downstream gene therapy manufacturing. Previously, Matthew completed an MBiolSci program at The University of Sheffield from September 2018 to July 2022, earning a Bachelor of Science degree in Biochemistry and Genetics.